1. Academic Validation
  2. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors

The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors

  • Bioorg Med Chem. 2007 May 15;15(10):3450-6. doi: 10.1016/j.bmc.2007.03.010.
Jung-Feng Hsieh 1 Shih-Hsiung Wu Yu-Liang Yang Kee-Fong Choong Shui-Tein Chen
Affiliations

Affiliation

  • 1 Institute of Biological Chemistry and the Genomics Research Center, Academia Sinica, Nankang, Taipei 115, Taiwan.
Abstract

Xanthine Oxidase (XO) is a key enzyme which can catalyze xanthine to uric acid causing hyperuricemia in humans. By using the fractionation technique and inhibitory activity assay, an active compound that prevents XO from reacting with xanthine was isolated from wheat leaf. It was identified by the Mass and NMR as 6-aminopurine (adenine). A structure-activity study based on 6-aminopurine was conducted. The inhibition of XO activity by 6-aminopurine (IC(50)=10.89+/-0.13 microM) and its analogues was compared with that by allopurinol (IC(50)=7.82+/-0.12 microM). Among these analogues, 2-chloro-6(methylamino)purine (IC(50)=10.19+/-0.10 microM) and 4-aminopyrazolo[3,4-d] pyrimidine (IC(50)=30.26+/-0.23 microM) were found to be potent inhibitors of XO. Kinetics study showed that 2-chloro-6(methylamino)purine is non-competitive, while 4-aminopyrazolo[3,4-d]pyrimidine is competitive against XO.

Figures
Products